Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Panion & BF Biotech Inc Announces New Drug Application for Nephoxil

Tuesday, 8 Oct 2013 08:51pm EDT 

Panion & BF Biotech Inc announced that it has authorize a United States-based company Keryx to filed new drug application (NDA) to Food and Drug Administration (FDA) for its new drug Nephoxil (named Zerenex in the United States), which is a kidney drug. 

Company Quote

1.96 +0.83%
1 Apr 2015